Elevra Lithium Produces 54,907 Tonnes, Targets 373,000 Annually After NAL Expansion
Key Facts
North American Lithium, owned by Elevra Lithium, produced about 54,907 dry metric tonnes of spodumene concentrate in the first quarter of fiscal 2027, up 1% from the previous quarter, according to the company’s quarterly activities report filed with the U.S. Securities and Exchange Commission. The mine recorded quarterly records for ore mined and processed, as the company targets raising average annual production to 373,000 tonnes once the NAL expansion is complete and operations stabilize. Chief Executive Lucas Dow said the September quarter was a “strong start to fiscal 2027,” with record mining and processing volumes. The company said the project moved into execution during the quarter and remains on schedule and budget and fully funded. A pre-feasibility study published in September linked higher production to improved plant feed grades, partly driven by ore sorting.
Ore mined totaled 466,499 wet metric tonnes, up 25% quarter on quarter and a quarterly record, while the plant processed 364,987 dry metric tonnes of ore, up 2%. The volume of ore processed set a quarterly record for the second consecutive quarter, the company said. Plant utilization was 91%, topping 90% for the third consecutive quarter despite a major planned shutdown. Lithium recovery, meanwhile, remained at an average of 70%, in line with the previous quarter, and the product concentrate grade averaged 5.1%. The figures show production growth was limited compared with the previous quarter, despite an increase in ore mined and processed and continued high plant utilization.
Sales exceeded production during the quarter, with Elevra selling about 58,134 dry tonnes of spodumene concentrate and generating revenue of $74 million, up 137% from the previous quarter. The average realized free-on-board selling price was $1,276 per dry tonne, up 39% quarter on quarter from $921. The company said final pricing for shipments would be settled in the December quarter, meaning the realized price for the quarter may not represent the final settlement for every shipment. At the same time, operating costs per tonne sold fell to $780 per dry tonne, from $907 in the previous quarter, a quarter-on-quarter decline of 14%. The quarter’s results therefore combined strong growth in revenue and sales with a higher realized price and lower unit operating costs.
The pre-feasibility study targets average annual production of 373,000 tonnes of spodumene concentrate once the expansion is complete and operations reach steady state, up 10% from the May 2026 estimate of 338,000 tonnes. The company said the improvement reflects higher plant feed grades, with ore sorting contributing, while the production target is nearly double the no-expansion scenario. The study estimated the project’s total initial capital expenditure at $271 million. It also estimated that average C1 operating costs over the expanded mine’s life would fall to $630 per tonne, 16% below the no-expansion case; all-in sustaining costs were estimated at $680 per tonne. These are estimates in the project study, while higher production remains contingent on completing the expansion and ramping up operations.
Elevra said expansion work entered the execution phase in the September quarter, with detailed engineering and long-lead equipment procurement progressing, equipment installation beginning and demolition of the old carbonate facility at NAL commencing. The company said the project remains on schedule and budget and is fully funded by the strategic funding package it announced in May 2026. A binding offtake agreement signed after the quarter with LG Energy Solution provides a commercial outlet for production, covering 240,000 dry tonnes of spodumene concentrate over three years, with the first shipment expected to begin in 2026. Cash stood at $319 million on September 30, up $63 million from June, and did not include proceeds of about $71 million from the sale of the Ewoyaa stake on October 26. On safety, Dow said performance “did not meet our expectations” after six recordable injuries in the September quarter, adding that the company would strengthen training, field leadership and risk controls. ELVR shares closed at $24.24 on November 5, 2026.